NA PCR-Based Transplant Diagnostics Market - Industry Trends and Forecast to 2035

Description

List of Tables

North America PCR based transplant diagnostics market is expected to reach USD 488,162.43 thousand by 2031, from USD 299,916.41 thousand in 2023 growing at the CAGR of 6.5% in the forecast period of 2024 to 2031.

Market Segmentation

North America PCR based Transplant diagnostics Market, By Test Type (CMV PCR Test, EBV PCR Test, BKV PCR Test, VZV PCR Test, HSV1 PCR TestHSV2 PCR Test, Parvovirus B19 PCR Test, P. Jirovecii PCR Test, JCV PCR Test, Adenovirus PCR Test, and Aspergillus Spp PCR Test), By Transplant Type (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Pancreas Transplantation, and Other Transplantations), Application (Diagnostic Applications and Research Applications), End User (Hospitals and Transplant Centers, Commercial Service Providers, Research Laboratories and Academic Institutes), Country (U.S., Canada, and Mexico)- Industry Trends and Forecast to 2031

Overview of North America PCR Based Transplant Diagnostics Market Dynamics

Driver
Rising popularity of non-invasive diagnostic methods
Restraint
High-cost of PCR/NGS software
Opportunity
Strategic initiation and technology launches by market players

Market Players

Some of the major market players for North America PCR based transplant diagnostics market are:

Quest Diagnostics Incorporated.,
Laboratory Corporation of America Holdings.
Sonic Healthcare USA
ARUP Laboratories.
Amber Lab

1 INTRODUCTION 12

1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF THE NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET 12
1.4 CURRENCY AND PRICING 13
1.5 LIMITATIONS 13
1.6 MARKETS COVERED 14

2 MARKET SEGMENTATION 16

2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 18
2.4 DBMR TRIPOD DATA VALIDATION MODEL 19
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.6 MULTIVARIATE MODELLING 23
2.7 TEST TYPE SEGMENT LIFELINE CURVE 23
2.8 MARKET END USER COVERAGE GRID 24
2.9 DBMR MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 26
2.11 SECONDARY SOURCES 27
2.12 ASSUMPTIONS 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 30

4.1 PESTAL ANALYSIS 31
4.2 PORTERS FIVE FORCES 32

5 MARKET OVERVIEW 33

5.1 DRIVERS 35
- 5.1.1 INCREASING PREVALENCE OF ORGAN FAILURE 35
- 5.1.2 RISING POPULARITY OF NON-INVASIVE DIAGNOSTIC METHODS 35
- 5.1.3 ADVANCEMENT IN ORGAN PRESERVATIVE TECHNIQUES 36
- 5.1.4 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES 37
5.2 RESTRAINTS 38
- 5.2.1 SHORTAGE OF PROFESSIONALS WITH EXPERTISE IN TRANSPLANT DIAGNOSTICS 38
- 5.2.2 HIGH COST OF PCR/NGS SOFTWARE 38
5.3 OPPORTUNITIES 39
- 5.3.1 STRATEGIC INITIATION AND TECHNOLOGY LAUNCHES BY MARKET PLAYERS 39
- 5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR PCR-BASED ORGAN TRANSPLANTATION 39
- 5.3.3 SURGE OF AWARENESS FOR ORGAN TRANSPLANTATION 40
5.4 CHALLENGES 41
- 5.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION 41
- 5.4.2 LACK OF ORGAN DONORS AND PROVIDERS ANNUALLY 42

6 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE 43

6.1 OVERVIEW 44
6.2 CMV PCR TEST 48
6.3 EBV PCR TEST 48
6.4 BKV PCR TEST 48
6.5 VZV PCR TEST 49
6.6 HSV1 PCR TEST 50
6.7 HSV2 PCR TEST 50
6.8 PARVOVIRUS B19 PCR TEST 50
6.9 P. JIROVECII PCR TEST 51
6.10 JCV PCR TEST 52
6.11 ADENOVIRUS PCR TEST 52
6.12 ASPERGILLUS SPP PCR TEST 53

7 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 54

7.1 OVERVIEW 55
7.2 KIDNEY TRANSPLANTATION 58
7.3 LIVER TRANSPLANTATION 59
7.4 HEART TRANSPLANTATION 59
7.5 LUNG TRANSPLANTATION 60
7.6 PANCREAS TRANSPLANTATION 60
7.7 OTHER TRANSPLANTATIONS 61

8 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 62

8.1 OVERVIEW 63
8.2 DIAGNOSTIC APPLICATIONS 66
8.3 RESEARCH APPLICATIONS 67

9 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER 68

9.1 OVERVIEW 69
9.2 HOSPITALS AND TRANSPLANT CENTERS 72
9.3 COMMERCIAL SERVICE PROVIDERS 73
9.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 73

10 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 74

10.1 NORTH AMERICA 76
- 10.1.1 U.S. 79
- 10.1.2 CANADA 81
- 10.1.3 MEXICO 83

11 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, COMPANY LANDSCAPE 85

11.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 85

12 SWOT ANALYSIS 86

13 COMPANY PROFILES 87

13.1 QUEST DIAGNOSTICS INCORPORATED. 87
- 13.1.1 COMPANY SNAPSHOT 87
- 13.1.2 REVENUE ANALYSIS 87
- 13.1.3 COMPANY SHARE ANALYSIS 88
- 13.1.4 PRODUCT PORTFOLIO 88
- 13.1.5 RECENT DEVELOPMENTS 89
13.2 LABORATORY CORPORATION OF AMERICA HOLDINGS. 90
- 13.2.1 COMPANY SNAPSHOT 90
- 13.2.2 REVENUE ANALYSIS 90
- 13.2.3 COMPANY SHARE ANALYSIS 91
- 13.2.4 PRODUCT PORTFOLIO 91
- 13.2.5 RECENT DEVELOPMENT 92
13.3 EUROFINS VIRACOR 93
- 13.3.1 COMPANY SNAPSHOT 93
- 13.3.2 COMPANY SHARE ANALYSIS 93
- 13.3.3 PRODUCT PORTFOLIO 94
- 13.3.4 RECENT DEVELOPMENTS 95
13.4 SONIC HEALTHCARE LIMITED 96
- 13.4.1 COMPANY SNAPSHOT 96
- 13.4.2 PRODUCT REVENUE ANALYSIS 96
- 13.4.3 COMPANY SHARE ANALYSIS 97
- 13.4.4 PRODUCT PORTFOLIO 97
- 13.4.5 RECENT DEVELOPMENTS 98
13.5 DR LAL PATHLABS. 99
- 13.5.1 COMPANY SNAPSHOT 99
- 13.5.2 REVENUE ANALYSIS 99
- 13.5.3 COMPANY SHARE ANALYSIS 100
- 13.5.4 PRODUCT PORTFOLIO 100
- 13.5.5 RECENT DEVELOPMENTS 101
13.6 ARUP LABORATORIES 102
- 13.6.1 COMPANY SNAPSHOT 102
- 13.6.2 PRODUCT PORTFOLIO 102
- 13.6.3 RECENT DEVELOPMENT 102
13.7 AMBAR LAB. 103
- 13.7.1 COMPANY SNAPSHOT 103
- 13.7.2 PRODUCT PORTFOLIO 103
- 13.7.3 RECENT DEVELOPMENTS 103

14 QUESTIONNAIRE 104

15 RELATED REPORTS 107

LIST OF TABLES

TABLE 1 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 47
TABLE 2 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 47
TABLE 3 NORTH AMERICA CMV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 48
TABLE 4 NORTH AMERICA EBV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 48
TABLE 5 NORTH AMERICA BKV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 49
TABLE 6 NORTH AMERICA VZV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 49
TABLE 7 NORTH AMERICA HSV1 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
TABLE 8 NORTH AMERICA HSV2 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 50
TABLE 9 NORTH AMERICA PARVOVIRUS B19 PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
TABLE 10 NORTH AMERICA P. JIROVECII PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 51
TABLE 11 NORTH AMERICA JCV PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 52
TABLE 12 NORTH AMERICA ADENOVIRUS PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 52
TABLE 13 NORTH AMERICA ASPERGILLUS SPP PCR TEST IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 53
TABLE 14 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 58
TABLE 15 NORTH AMERICA KIDNEY TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 58
TABLE 16 NORTH AMERICA LIVER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
TABLE 17 NORTH AMERICA HEART TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 59
TABLE 18 NORTH AMERICA LUNG TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 19 NORTH AMERICA PANCREAS TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 60
TABLE 20 NORTH AMERICA OTHER TRANSPLANTATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 61
TABLE 21 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 66
TABLE 22 NORTH AMERICA DIAGNOSTIC APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 66
TABLE 23 NORTH AMERICA RESEARCH APPLICATION IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 67
TABLE 24 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 72
TABLE 25 NORTH AMERICA HOSPITALS AND TRANSPLANT CENTERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 72
TABLE 26 NORTH AMERICA COMMERCIAL SERVICE PROVIDERS IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
TABLE 27 NORTH AMERICA RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY REGION, 2022-2031 (USD THOUSAND) 73
TABLE 28 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 76
TABLE 29 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 76
TABLE 30 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 77
TABLE 31 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 77
TABLE 32 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 77
TABLE 33 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 78
TABLE 34 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 79
TABLE 35 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 79
TABLE 36 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 80
TABLE 37 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 80
TABLE 38 U.S. PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 80
TABLE 39 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 81
TABLE 40 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 81
TABLE 41 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 82
TABLE 42 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 82
TABLE 43 CANADA PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 82
TABLE 44 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND) 83
TABLE 45 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2031 (NUMBER OF TESTS) 83
TABLE 46 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE, 2022-2031 (USD THOUSAND) 84
TABLE 47 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 84
TABLE 48 MEXICO PCR BASED TRANSPLANT DIAGNOSTICS MARKET, BY END USER, 2022-2031 (USD THOUSAND) 84

LIST OF FIGURES

FIGURE 1 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 16
FIGURE 2 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DATA TRIANGULATION 19
FIGURE 3 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DROC ANALYSIS 20
FIGURE 4 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: NORTH AMERICA VS REGIONAL MARKET SHARE ANALYSIS 21
FIGURE 5 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 21
FIGURE 6 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 22
FIGURE 7 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 24
FIGURE 8 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 25
FIGURE 9 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 26
FIGURE 10 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SEGMENTATION 29
FIGURE 11 INCREASING PREVALENCE OF ORGAN FAILURE IS EXPECTED TO DRIVE THE GROWTH OF THE NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET FROM 2024 TO 2034 30
FIGURE 12 CMV PCR TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET IN 2024 TO 2031 30
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET 34
FIGURE 14 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2023 44
FIGURE 15 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, 2024-2031 (USD THOUSAND) 45
FIGURE 16 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2024-2031) 45
FIGURE 17 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TEST TYPE LIFELINE CURVE 46
FIGURE 18 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2023 55
FIGURE 19 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, 2024-2031 (USD THOUSAND) 56
FIGURE 20 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, CAGR (2024-2031) 56
FIGURE 21 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY TRANSPLANT TYPE, LIFELINE CURVE 57
FIGURE 22 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2023 63
FIGURE 23 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND) 64
FIGURE 24 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: APPLICATION, CAGR (2024-2031) 64
FIGURE 25 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 65
FIGURE 26 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2023 69
FIGURE 27 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, 2024-2031 (USD THOUSAND) 70
FIGURE 28 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, CAGR (2024-2031) 70
FIGURE 29 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 71
FIGURE 30 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: SNAPSHOT (2023) 75
FIGURE 31 NORTH AMERICA PCR BASED TRANSPLANT DIAGNOSTICS MARKET: COMPANY SHARE 2023 (%) 85